Risperdal & Gynecomastia
Risperdal Lawsuits are on the Rise
Families across the country have filed legal claims against the makers of the antipsychotic drugs Risperdal and Invega. Risperdal is also referred to with its generic moniker of “risperidone.” The pseudonym for Invega is “paliperidone.” Johnson & Johnson along with its Janssen unit are facing countless lawsuits from plaintiffs who argue the use of Risperdal and Invega results in an enlargement of male breast tissue. This medical condition is commonly referred to as “gynecomastia.” Others refer to it as “man boobs.” This condition results in severe physical and emotional damage as well as social awkwardness.
Gynecomastia often leads to a mastectomy in which the breasts are removed. Such an operation is typical of women who suffer from breast cancer yet rarely required of boys or men. The physical, financial, spiritual and emotional damage from gynecomastia and a mastectomy cannot be understated. This is precisely why so many families are being proactive and taking legal action against the makers of Risperdal and Invega. If you have experienced any breast enlargement after using Risperdal or Invega, you might be entitled to compensation. The same is true of those who suffered any other sort of complications after using these drugs.
Why so Many Risperdal and Invega Lawsuits are Being Filed
Both Risperdal and Invega qualify as “atypical antipsychotics” that alter the effects of chemicals on the brain. Risperidone has also been made available in the form of an injection referred to as “Risperdal Consta”. This is the generic version of the drug produced by Patriot. The United States Department of Justice has confirmed Johnson & Johnson marketed both drugs in an illegal manner. A statement made by an individual who once managed sales for Johnson & Johnson shows the company failed to obtain the Food and Drug Administration’s (FDA) approval before touting the drug’s alleged benefits for children. This sales manager testified at a Risperdal trial in Pennsylvania that Johnson & Johnson trained its sales staff to market Risperdal to children’s physicians as far back as 2003. The company allegedly ordered such a sales push with full awareness that the FDA had not yet approved the drug for use in children. Johnson & Johnson is also accused of buying off doctors so they would speak highly of the drug’s antipsychotic capabilities. There are also accusations that the company sponsored golf outing and provided some other incentives to encourage doctors to prescribe Risperdal to kids and teens.
Johnson & Johnson and Janssen were already suspected of illegal behavior after allegations surfaced of their illegal advertising efforts between 1993 and 2004. Consumer protection agencies across 36 states put the company in their cross-hairs. By May of
2012, the attorney general of Kentucky had announced the filing of a lawsuit against the company for hiding the harmful side effects of both drugs. Examples of such alleged side effects include gynecomastia, stroke, diabetes and considerable weight gain. It took only three months for these lawsuits to result in an agreement between the companies and some states to settle claims of corporate misconduct. This agreement resulted in Johnson & Johnson and Janssen’s payment of hundreds of millions of dollars to numerous states.
Help is Available for Those who Have Been Negatively Affected by Risperdal and Invega
Our team is dedicated to assisting those who have endured physical and mental harm as a result of taking Risperdal. We have a considerable amount of information that will help you cope with the medical and financial damage caused by this dangerous drug. Take a look at our website and reach out to us for free information and extensive support. If you or anyone you know has endured harm as a result of taking Risperdal, do not hesitate to contact our patient advocates. We provide the following services:
Answers to Your Legal Questions: The legal process is quite complicated. There are all sorts of legal nuances and bureaucratic court requirements to tend to. You can trust our patient advocates to answer your questions about legal recourse and how the legal process works.
Regular Availability: If you have any questions about a potential lawsuit against Johnson & Johnson and Janssen regarding the alleged harmful effects of Risperdal or Invega, do not hesitate to ask for assistance. Our patient advocate team is available throughout the week to tend to your questions and concerns.
Legal Resources: If you are interested in filing a lawsuit, we will help you team up with highly skilled and experienced practitioners of law.
The Current Status of Risperdal and Invega Claims
All in all, thousands of lawsuits have been filed on behalf of injured children, adolescents and young men of all ages. These lawsuits span numerous states. The fact that Risperdal has been the subject of multiple lawsuits over its alleged diabetes risks has led the state of New Jersey to centralize these cases under its mass tort procedures. It is quite possible that federal and state courts will also decide to centralize Risperdal/gynecomastia cases as the number of claims continues to skyrocket. Each of these cases is currently at its unique point in the litigation process. In some instances, trials have already begun. Take a look at the Risperdal gynecomastia settlements as of today:
- Johnson & Johnson settled a case in September of 2012 for an undisclosed amount of money. This settlement was finalized on the first day of the trial in the state court of Pennsylvania.
- In October of 2012, Johnson & Johnson settled five additional cases in Philadelphia courts.
- By November of 2013, Johnson & Johnson reneged on settlements with a whopping 77 patients just before the agreements were completed.
- As time progresses, additional lawsuits will be filed against Johnson & Johnson and Janssen. More settlements will likely result.
A report issued by Bloomberg states Risperdal sales totaled an incredible $24.2 billion between 2003 and 2010. The profit motive is clearly the driving force behind Johnson & Johnson’s unwillingness to admit any wrongdoing in multistate investigations. The company still refuses to admit wrongdoing even though it has reached numerous settlements as a result of Risperdal lawsuits. Johnson & Johnson is currently conducting settlement talks with some states. Johnson & Johnson is also battling with the Justice Department to boot.
Johnson & Johnson’s Fines and Court Awards
- The state of Arkansas has fined Johnson & Johnson a total of $1.2 billion for improper advertising.
- The company reached an agreement with the state of Texas for $158 million following its agreement with Arkansas.
- Johnson & Johnson was ordered to pay $257.7 million to the state of Louisiana for misleading regulators about Risperdal’s health risks and defrauding the state’s Medicaid program.
- South Carolina won a $327 million award from Johnson & Johnson after claiming the company transmitted marketing letters to physicians to exaggerate the safety of Risperdal.
Should You File a Lawsuit?
Some independent researchers have found that the link between the use of Risperdal and Invega and adolescent gynecomastia is stronger than any other anti-psychotic drug. This is in direct conflict with Johnson & Johnson’s claims that the drug has an unparalleled safety profile. If you have any suspicion as to whether Risperdal or Invega has negatively affected your life, do not hesitate to reach out for legal assistance.
Injured Parties’ Claims Against Johnson & Johnson and Janssen
- Concealment of the magnitude of the drugs’ health risks
- Illegally marketing Risperdal to kids as a means of treating autism and psychiatric disorders despite a failure to obtain FDA approval from 1993-2004.
- Numerous physical and emotional injuries.
- Misrepresenting the drugs’ benefits and risks for children.
- Expenses for hospitalization, coping expenses, lost employment time and the restoration of quality of life.
Illegal Advertising to Children
In November of 2013, Johnson & Johnson came to terms on an agreement in which it would pay $2.2 billion to settle civil and criminal claims for improper Risperdal marketing. Complaints filed by injured individuals and government officials state the company promoted the drug to children in 1994 and beyond even though the FDA had not yet decided whether clinical evidence to support the drug’s alleged merit actually existed. Complaints also state Johnson & Johnson illegally touted the drug to pediatric and elderly patients who suffer from Alzheimer’s disease, anxiety, depression and a number of other disorders/maladies.
Johnson & Johnson’s Alleged Marketing Campaign to Convince Physicians to Prescribe Risperdal
According to federal lawsuits, Johnson & Johnson planned marketing campaigns to sway physicians to prescribe Risperdal for illegitimate purposes. The plan was centered on providing physicians with thousands of free samples, rewarding physicians for prescriptions, paying doctors to learn about Risperdal’s unapproved uses and providing kickbacks to pharmacies/nursing homes for promoting the drug.
Free Case Review
Anyone who has taken Risperdal or Invega and experienced complications such as gynecomastia should not suffer in silence. Legal options are available. Contact us today for a free case review.